Evidence map›Paper›PMID 42270652›Full record

ArticleNature communications2026

Divergent C2 functionalization of N-Heteroarenes via nonclassical rearomatization.

Lei Huang, Huilong Zhu, Nan Wu, Du Luo, Yunsheng Xue, Zhou Xu

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lei Huang *School of Pharmacy, Xuzhou Medical University, Xuzhou, Jiangsu, 221004, P. R. China.
Huilong Zhu *School of Pharmacy, Xuzhou Medical University, Xuzhou, Jiangsu, 221004, P. R. China.
Nan Wu *School of Pharmacy, Xuzhou Medical University, Xuzhou, Jiangsu, 221004, P. R. China.
Du LuoSchool of Pharmacy, Xuzhou Medical University, Xuzhou, Jiangsu, 221004, P. R. China.
Yunsheng XueSchool of Pharmacy, Xuzhou Medical University, Xuzhou, Jiangsu, 221004, P. R. China.
Zhou XuSchool of Pharmacy, Xuzhou Medical University, Xuzhou, Jiangsu, 221004, P. R. China. xuzhou@xzhmu.edu.cn.ORCID http://orcid.org/0009-0007-1331-1683

Funding

Basic Research Program of Jiangsu Province BK20251924National Natural Science Foundation of China (National Science Foundation of China) 21602191
6 · The paper itself

Abstract

Site-selective functionalization of N-heteroarenes remains a persistent challenge due to their intrinsic aromatic stabilization and multiple reactive sites. We present a unified strategy that redirects the reactivity of N-alkenyloxy-heteroarenium salts to access two distinct product classes. Under Grignard-reagent conditions, pyridinium substrates undergo ultrafast C2-functionalization via a concerted, six-electron retro-hetero-ene rearrangement-a transformation not previously described-delivering ortho-substituted pyridines (alkyl, aryl, heteroaryl, alkynyl) in up to 93% yield. In contrast, quinolinium salts engage in a cascade involving C2‑addition, a 3,3‑sigmatropic rearrangement, cycloaddition and dehydration to furnish N‑bridged polycyclic frameworks efficiently. Notably, the reaction pathway is governed by substrate sterics; C8 substitution on quinoline switches the mechanism to the retro-hetero-ene route. The method is scalable, enables late-stage diversification of complexed scaffolds and site-selective deuterium labeling. Here we show that this strategy, supported by mechanistic and computational studies, establishes a versatile platform for heteroarene editing via nonclassical rearomatization.

Identifiers

PMID42270652
PMCPMC13402295

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.